VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

FASEB Journal

Volumn 13, Issue 1, 1999, Pages 181-189

  Zhai, Yifan ^a   Ni, Jian ^a   Jiang, Gong Wei ^a   Lu, Jiamo ^a   Xing, Lily ^a   Lincoln, Clint ^a   Carter, Kenneth C ^a   Janat, Fouad ^a   Kozak, Diane ^a   Xu, Simin ^a   Rojas, Lorena ^a   Aggarwal, Bharat B ^b   Ruben, Steve ^a   Li, Lu Yuan ^c   Gentz, Reiner ^a   Yu, Guo Liang ^a  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Anti angiogenesis; Anti tumor; Cytokine; EST; TNF

Indexed keywords

TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATTLE; CELL PROLIFERATION; CHROMOSOME 9Q; COLON CARCINOMA; GENE MAPPING; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; BOVINAE; MURINAE;

EID: 0032906102     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.1.181     Document Type: Article

References (22)

1. Aggarwal, B. B., and Natarajan, K. (1996) Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7, 93-124
2. Tewari, M., and Dixit, V. M. (1996) Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6, 39-44
3. Baker, S. J., and Reedy, E. P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9
4. Chinnaiyan A. M., and Dixit, V. M. (1997) Portrait of an executioner: the molecular mechanism if FAS/APO-1-induced apoptosis. Semin. Immunol. 9, 69-76
5. Depraetere V., and Golstein, P. (1997) Fas and other cell death signaling pathways. Semin. Immunol. 9, 93-107
6. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., and Goodwin, R. G. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682
7. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., and Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690
8. Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y. M., Scott, H., Hession, C., Garcia, I., and Browning, J. L. (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272, 32401-32410
9. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H. L., Steinman, R. M., Choi Y. (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080
10. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-rell function. Nature (London) 390, 175-179
11. Zhai, Y., Guo, R., Hsu, T., Yu, G. L., Ni, J., Kwon, B. S., Jiang. G., Lu, J., Tan, J., Ugustus, M., Carter, K., Rojas, L., Zhu, F., Lincoln, C., Endress, G., Xing, X., Wang, S., Oh, K. O., Gentz, R., Ruben, S., Lippman, M. E., Hsieh, S. L., and Yang, D. (1998) LIGHT, a novel ligand for lymphotoxin b receptor and TR2 induces apoptosis and displays anti-tumor activity in vivo via gene transfer. J. Clin. Invest. 102, 1142-1151
12. Adams, M. D., Kelley, J. M., Gocayne, J. D., Dubnick, M., Polymeropoulos, M. H., Xiao, H., Merril, C. R., Wu, A., Oide, B., Moreno, R. F., Kerlavage, A. R., McCombie, W. R., and Venter, J. C. (1991) Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252: 1651-1656
13. Tan, K. B., Harrop, J., Reddy, M., Young, P., Terrett, J., Emery, J., Moore, G., Truneh, A. (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204, 35-46
14. Havell, E. A., Fiers, W., and North, R. J. (1990) The anti-tumor function of tumor necrosis factor (TNF). J. Exp. Med. 167, 1067-1085
15. Asher, A. L., Mule, J. J., Reichert, C. M., Shiloni, E., and Rosenberg, S. A. (1987) Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol. 138, 963-974
16. Blankenstein, T., Qin, Z. H., Uberla, K., Muller, W., Rosen, H., Volk, H. D., Diamantstein, T. (1991) Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J. Exp. Med. 173: 1047-1052
17. Seino, K., Kayagaki, N., Okaumura, K., and Yagita, H. (1997) Anti-tumor effect of locally produced CD95 ligand. Nature Med. 3, 165-170
18. Lotze, M. T., Zitvogel, L., Campbell, R., Robbins, P. D., Elder, E., Haluszczak, C., Martin, D., Whiteside, T. L., Storkus, W. J., and Tahara, H. (1997) Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. Ann. N.Y. Acad. Sci. 795, 440-454
19. Hussein, A. M. (1996) The potential applications of gene transfer in the treatment of patients with cancer: a concise review. Cancer Invest. 14, 343-352
20. O'Reilly, M. S., Boehm, T., Shing, T., Fukai, N., Vasios, G., Lane, W.S ., Flynn, E., Birkhead, J. R., Olson, B. R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285
21. Boehm, T., Folkman, J., Browder, T., and O'Reilly M. S. (1997) Antiangiogeneic therapy of experimental cancer does not induce acquired drug resistance. Nature (London) 390, 404-407
22. Wang, H. U., Chen, Z. F., and Anderson, D. J. (1998) Molecular distinction and angiogenic interaction between embryonic articles and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753